Scott Braunstein is President, Chief Executive Officer and Director of Marinus Pharmaceuticals, Inc. (MRNS). The company reported total compensation of $3,214,100 for fiscal year 2023.
| Salary | $650,000 |
|---|---|
| Bonus | $351,000 |
| Stock awards | $1,728,000 |
| Option awards | $475,200 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $9,900 |
| Total | $3,214,100 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Marinus Pharmaceuticals, Inc. filed April 4, 2024, accession 0001558370-24-004691.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2023 | President, Chief Executive Officer and Director | $650,000 | $351,000 | $1,728,000 | $475,200 | $0 | $0 | $9,900 | $3,214,100 |
| FY2022 | President, Chief Executive Officer and Director | $591,000 | $319,140 | $1,669,828 | $542,878 | $0 | $0 | $9,150 | $3,131,996 |
Totals as disclosed in each year's own compensation disclosure for Marinus Pharmaceuticals, Inc..
| Named executive officer | Role | FY2023 total |
|---|---|---|
| Scott Braunstein this page | President, Chief Executive Officer and Director | $3,214,100 |
| Steven Pfanstiel | Chief Operating Officer, Chief Financial Officer and Treasurer | $1,444,950 |
| Joseph Hulihan | Chief Medical Officer | $1,371,829 |
The company's named executive officers for fiscal year 2023, and what it reported for each. See the full Marinus Pharmaceuticals, Inc. compensation brief.
Scott Braunstein's compensation sits inside Marinus Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.